Granules India Limited (GRANULES.NS) Financials
GRANULES.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2025 | 62.5 billion | 25.4 billion |
| Dec. 31, 2024 | ? | -34.3 billion |
| Sept. 30, 2024 | 54.3 billion | 20.1 billion |
| June 30, 2024 | ? | ? |
GRANULES.NS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2025 | ? | ? |
| Dec. 31, 2024 | ? | ? |
| Sept. 30, 2024 | ? | ? |
| June 30, 2024 | ? | ? |
GRANULES.NS Net Income
| Date | Net Income |
|---|---|
| March 31, 2025 | 6.6 billion |
| Dec. 31, 2024 | 1.2 billion |
| Sept. 30, 2024 | 972.3 million |
| June 30, 2024 | 1.3 billion |
GRANULES.NS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2025 | 6.0 billion | 4.7 billion | 1.6 billion |
| Dec. 31, 2024 | 2.2 billion | - | - |
| Sept. 30, 2024 | 2.2 billion | 2.4 billion | 877.8 million |
| June 30, 2024 | 3.8 billion | - | - |
GRANULES.NS Shares Outstanding
GRANULES.NS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2025 | 5.7 billion | - | 3.4 billion | - |
| Dec. 31, 2024 | - | - | 1.7 billion | - |
| Sept. 30, 2024 | 2.8 billion | - | 1.6 billion | - |
| June 30, 2024 | - | - | 2.7 billion | - |
GRANULES.NS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2025 | 12.0 billion | 6.7 billion |
| Dec. 31, 2024 | 11.3 billion | 4.4 billion |
| Sept. 30, 2024 | 9.6 billion | 3.7 billion |
| June 30, 2024 | 11.8 billion | 7.0 billion |
GRANULES.NS
Price: ₹770.85
Dividend Yield: 0.26%
Forward Dividend Yield: 0.22%
Payout Ratio: 7.39%
Dividend Per Share: 1.75 INR
Earnings Per Share: 22.47 INR
P/E Ratio: 25.68
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: India
Market Capitalization: 140.0 billion
Average Dividend Frequency: 1
Years Paying Dividends: 22